Investor Presentaiton
U.S.
Other
listed
peers
peers
Eurofins Pharma Services in more detail
Spanning the entire drug development cycle
eurofins
Genomics
Sequencing
Oligonucleotides
Pharmacogenomics
Transcriptomics
Genotyping
SNP-analysis
IDT/Danaher,
Genewiz/Brooks
Discovery
Pharmacology
High-throughput-
screening
Molecular- Pharmacology
Cell-based Assays
In Vitro Screening
In Vitro Profiling
In Vivo Safety
In Vivo efficacy
Charles River
Pre-clinical/ Early
Development
Pharmacology
Bioanalytical Analysis
Translational Medicine
Phase I Studies
Catalent, Charles
River, ICON, IQVIA,
LabCorp, Syneos
Health, PPD
Clinical (Central
Laboratory/
Bioanalytical)
Biomarkers
Bioanalysis
Immunogenicity
Proteomics
Microbiological and Anti-
infective analysis
Bioavailability
Bioequivalence
Charles River, ICON,
IQVIA, LabCorp,
Quest,
Syneos Health, PPD
Development
& Manufacturing
(CDMO)
Complex API
Development
Multi-Step Synthesis
Cytotoxic and Highly
Potent
DS and DP
Manufacturing
Catalent, Charles
River
BioPharma
Products Testing
Pharmaceuticals,
Biologics, Medical
Device: Safety,
Characterization,
Quality Control,
Process Development
Hygiene Monitoring
Packaging
Charles River, PPD
Abcam, etc.
Evotec, Abcam,
Albany Molecular
Research, etc.
Evotec, Parexel, etc.
Albany Molecular
Research, etc.
Albany Molecular
Research,
Lonza, Cambrex etc.
SGS,
Wu Xi App Tec, etc.
32
32View entire presentation